Skip to main content
Log in

Etanercept of value in rheumatoid arthritis

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Taylor M, Trueman P, Reynolds AV, Conway P.Economic benefits of etanercept following anti-TNF treatment in patients with rheumatoid arthritis: an analysis using tempo data. Rheumatology 46 (Suppl. 1): abstr. 258, Apr 2007

  2. Taylor M, Trueman P, Reynolds AV, Conway P.Costs and benefits of etanercept followed by rituximab at different stages of the treatment sequence in patients with rheumatoid arthritis. Rheumatology 46 (Suppl. 1): abstr. OP52, Apr 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Etanercept of value in rheumatoid arthritis. Pharmacoecon. Outcomes News 529, 1 (2007). https://doi.org/10.2165/00151234-200705290-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705290-00001

Keywords

Navigation